Literature DB >> 26434410

Outcomes of living donor renal transplantation in children with lower urinary tract dysfunction: a comparative retrospective study.

Ismail R Saad1, Enmar Habib1, Mohammed S ElSheemy1, Mahmoud Abdel-Hakim1, Mostafa Sheba1, Aziz Mosleh1, Doaa M Salah2, Hafez Bazaraa2, Fatina I Fadel2, Hany A Morsi1, Hesham Badawy1.   

Abstract

OBJECTIVES: To compare outcomes of renal transplantation (RTx) in children with end-stage renal disease (ESRD) resulting from lower urinary tract dysfunction (LUTD) vs other causes. PATIENTS AND METHODS: A database of children (<18 years old) who underwent RTx between May 2008 and April 2012 was reviewed. Patients were divided into those with LUTD (group A, n = 29) and those with other causes of ESRD (group B, n = 74). RTx was performed after achieving low intravesical pressure (<30 cmH2 O) with adequate bladder capacity and drainage. The groups were compared using Student's t-test, Mann-Whitney, chi-squared or exact tests. Graft survival rates (GSRs) were evaluated using Kaplan-Meier curves and the log-rank test.
RESULTS: The mean ± sd (range) age of the study cohort was 5.05 ± 12.4 (2.2-18) years. Causes of LUTD were posterior urethral valve (PUV; 41.4%), vesico-ureteric reflux (VUR; 37.9%), neurogenic bladder (10.3%), prune belly syndrome (3.4%), obstructive megaureter (3.4%) and urethral stricture disease (3.4%). There was no significant difference in age, dialysis duration or donor type. In group A, 25 of the 29 patients (86.2%) underwent ≥1 surgery to optimize the urinary tract for allograft. Pretransplant nephrectomy was performed in 15 of the 29 patients (51.7%), PUV ablation in nine patients (31%) and ileocystoplasty in four patients (13.7%). The mean ± sd follow-up was 4.52 ± 1.55 and 4.07 ± 1.27 years in groups A and B, respectively. There was no significant difference in creatinine and eGFR between the groups at different points of follow-up. The GSRs at the end of the study were 93.1 and 91.1% in groups A and B, respectively (P = 1.00). According to Kaplan-Meier survival curves, there was no significant difference in the GSR between the groups using the log-rank test (P = 0.503). No graft was lost as a result of urological complications. In group B, one child died from septicaemia. The rate of urinary tract infections was 24 and 12% in groups A and B, respectively, but was not significant. No significant difference was found between the groups with regard to the incidence of post-transplantation hydronephrosis. Of the 22 patients who had hydronephrosis after transplantation, three were complicated by UTI. Injection of bulking agents was required in two patients for treatment of grade 3 VUR. In the third patient, augmentation cystoplasty was needed.
CONCLUSION: Acceptable graft function, survival and UTI rates can be achieved in children with ESRD attributable to LUTD. Thorough assessment and optimization of LUT, together with close follow-up, are key for successful RTx.
© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  children; live donor; lower urinary tract dysfunctions; renal transplantation

Mesh:

Year:  2015        PMID: 26434410     DOI: 10.1111/bju.13347

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  3 in total

Review 1.  Current strategies to predict and manage sequelae of posterior urethral valves in children.

Authors:  Aniruddh V Deshpande
Journal:  Pediatr Nephrol       Date:  2017-11-20       Impact factor: 3.714

Review 2.  Egyptian clinical practice guideline for kidney transplantation.

Authors:  Ahmed A Shokeir; Saddam Hassan; Tamer Shehab; Wesam Ismail; Ismail R Saad; Abdelbasset A Badawy; Wael Sameh; Hisham M Hammouda; Ahmed G Elbaz; Ayman A Ali; Rashad Barsoum
Journal:  Arab J Urol       Date:  2021-01-03

3.  Renal transplantation into optimized abnormal lower urinary tract - Impact on graft outcomes, patient survival, and complications.

Authors:  Selvin Theodore Jayanth; Anuj Deep Dangi; Rajiv Paul Mukha; Santosh Kumar; Santosh Varughese; Vinoi G David; Anna Valson; J Chandrasingh; Antony Devasia; Nitin Kekre
Journal:  Indian J Urol       Date:  2019 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.